{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T00:52:06Z","timestamp":1793407926141,"version":"4.5.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T00:00:00Z","timestamp":1783382400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["advancesradonc.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Radiation Oncology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.adro.2026.102141","type":"journal-article","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T15:06:04Z","timestamp":1783782364000},"page":"102141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Early Clinical Outcomes and Local Control Following Spine Stereotactic Proton Ablative Radiation Therapy"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4807-1655","authenticated-orcid":false,"given":"Jingjing Michele","family":"Dougherty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman O.","family":"Kowalchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel K.","family":"Ebner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth W.","family":"Merrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin A.","family":"Johnson-Tesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William S.","family":"Harmsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G.","family":"Breen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satomi","family":"Shiraishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Iott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley J.","family":"Stish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon J.","family":"Kruse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris J.","family":"Beltran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony L.","family":"Mikula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia N.","family":"Laack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Foote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth R.","family":"Olivier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1099-1763","authenticated-orcid":false,"given":"Trey C.","family":"Mullikin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3814-853X","authenticated-orcid":false,"given":"Sean S.","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.adro.2026.102141_bib0001","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000\u201314 (CONCORD-3): Analysis of individual records for 37\u2008513\u2008025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries","volume":"391","author":"Allemani","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.adro.2026.102141_bib0002","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.nec.2004.04.004","article-title":"Evolution of treatment for metastatic spine disease","volume":"15","author":"Wu","year":"2004","journal-title":"Neurosurg Clin N Am"},{"key":"10.1016\/j.adro.2026.102141_bib0003","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1016\/j.ejso.2017.05.006","article-title":"Evolution in treatment strategy for metastatic spine disease: Presently evolving modalities","volume":"43","author":"Kumar","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.adro.2026.102141_bib0004","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1001\/jamaoncol.2019.5351","article-title":"Stereotactic ablative radiotherapy for the management of spinal metastases: A review","volume":"6","author":"Glicksman","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.adro.2026.102141_bib0005","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.prro.2013.05.001","article-title":"RTOG 0631 phase 2\/3 study of image guided stereotactic radiosurgery for localized (1-3) spine metastases: Phase 2 results","volume":"4","author":"Ryu","year":"2014","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.adro.2026.102141_bib0006","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1016\/j.ijrobp.2018.06.073","article-title":"Phase III multi-center, prospective randomized trial comparing high dose single fraction radiation therapy to a 3-fraction SBRT regimen in the treatment of oligometastatic human cancer","volume":"102","author":"Zelefsky","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102141_bib0007","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ijrobp.2021.01.004","article-title":"Phase III multi-center, prospective, randomized trial comparing single dose 24 Gy radiotherapy to a 3-fraction SBRT regimen in the treatment of oligometastatic cancer","volume":"110","author":"Zelefsky","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102141_bib0008","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3171\/2017.2.SPINE16976","article-title":"Reirradiation spine stereotactic body radiation therapy for spinal metastases: Systematic review","volume":"27","author":"Myrehaug","year":"2017","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.adro.2026.102141_bib0009","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jamaoncol.2020.0147","article-title":"Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: The ORIOLE phase 2 randomized clinical trial","volume":"6","author":"Phillips","year":"2020","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.adro.2026.102141_bib0010","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1200\/JCO.19.00201","article-title":"Local consolidative therapy vs. maintenance therapy or observation for patients with oligometastatic non\u2013small-cell lung cancer: Long-term results of a multi-institutional, phase II, randomized study","volume":"37","author":"Gomez","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2026.102141_bib0011","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1200\/JCO.2017.75.4853","article-title":"Surveillance or metastasis-directed therapy for oligometastatic prostate cancer recurrence: A prospective, randomized, multicenter phase II trial","volume":"36","author":"Ost","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.adro.2026.102141_bib0012","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2017.3501","article-title":"Consolidative radiotherapy for limited metastatic non\u2013small-cell lung cancer: A phase 2 randomized clinical trial","volume":"4","author":"Iyengar","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.adro.2026.102141_bib0013","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): A randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.adro.2026.102141_bib0014","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.radonc.2020.04.003","article-title":"Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document","volume":"148","author":"Lievens","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2026.102141_bib0015","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/neuonc\/not155","article-title":"Technique, outcomes, and acute toxicities in adults treated with proton beam craniospinal irradiation","volume":"16","author":"Barney","year":"2014","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.adro.2026.102141_bib0016","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.radonc.2016.01.002","article-title":"Thoracolumbar spinal cord tolerance to high dose conformal proton-photon radiation therapy","volume":"119","author":"Chowdhry","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2026.102141_bib0017","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1097\/BRS.0000000000000804","article-title":"Postoperative proton therapy for chordomas and chondrosarcomas of the spine: Adjuvant versus salvage radiation therapy","volume":"40","author":"Holliday","year":"2015","journal-title":"Spine (Phila Pa 1976)"},{"key":"10.1016\/j.adro.2026.102141_bib0018","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ijrobp.2016.01.057","article-title":"A prospective outcomes study of proton therapy for chordomas and chondrosarcomas of the spine","volume":"95","author":"Indelicato","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102141_bib0019","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20130512","article-title":"Particle therapy using carbon ions or protons as a definitive therapy for patients with primary sacral chordoma","volume":"87","author":"Mima","year":"2014","journal-title":"Br J Radiol"},{"key":"10.1016\/j.adro.2026.102141_bib0020","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.ijrobp.2021.02.014","article-title":"Ultrahypofractionated proton radiation therapy in the treatment of low and intermediate-risk prostate cancer-5-year outcomes","volume":"110","author":"Kube\u0161","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102141_bib0021","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s13014-019-1417-7","article-title":"3 fraction pencil-beam scanning proton accelerated partial breast irradiation: Early provider and patient reported outcomes of a novel regimen","volume":"14","author":"Mutter","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.adro.2026.102141_bib0022","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ijrobp.2018.02.022","article-title":"Phase 2 study of stereotactic body radiation therapy and stereotactic body proton therapy for high-risk, medically inoperable, early-stage non-small cell lung cancer","volume":"101","author":"Nantavithya","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102141_bib0023","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/JTO.0b013e31824de0bf","article-title":"Proton SBRT for medically inoperable stage I NSCLC","volume":"7","author":"Westover","year":"2012","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.adro.2026.102141_bib0024","article-title":"First ever use of proton stereotactic body radiation therapy delivered with curative intent to bilateral synchronous primary renal cell carcinomas","volume":"9","author":"Frick","year":"2017","journal-title":"Cureus"},{"key":"10.1016\/j.adro.2026.102141_bib0025","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1118\/1.4921046","article-title":"A fast GPU-based Monte Carlo simulation of proton transport with detailed modeling of nonelastic interactions","volume":"42","author":"Wan Chan Tseung","year":"2015","journal-title":"Med Phys"},{"key":"10.1016\/j.adro.2026.102141_bib0026","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.ijrobp.2016.03.041","article-title":"Clinically applicable Monte Carlo\u2013based biological dose optimization for the treatment of head and neck cancers with spot-scanning proton therapy","volume":"95","author":"Wan Chan Tseung","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102141_bib0027","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.ijrobp.2010.08.021","article-title":"Reirradiation human spinal cord tolerance for stereotactic body radiotherapy","volume":"82","author":"Sahgal","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102141_bib0028","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1118\/1.3438081","article-title":"Stereotactic body radiation therapy: The report of AAPM Task Group 101","volume":"37","author":"Benedict","year":"2010","journal-title":"Med Phys"},{"key":"10.1016\/j.adro.2026.102141_bib0029","doi-asserted-by":"crossref","first-page":"e595","DOI":"10.1016\/S1470-2045(15)00166-7","article-title":"Response assessment after stereotactic body radiotherapy for spinal metastasis: A report from the SPIne response assessment in Neuro-Oncology (SPINO) group","volume":"16","author":"Thibault","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2026.102141_bib0030","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jamaoncol.2021.7008","article-title":"Development and assessment of a predictive score for vertebral compression fracture after stereotactic body radiation therapy for spinal metastases","volume":"8","author":"Kowalchuk","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.adro.2026.102141_bib0031","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1016\/j.prro.2022.01.011","article-title":"Development and internal validation of a recursive partitioning analysis-based model predictive of pain flare incidence after spine stereotactic body radiation therapy","volume":"12","author":"Kowalchuk","year":"2022","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.adro.2026.102141_bib0032","doi-asserted-by":"crossref","first-page":"110260","DOI":"10.1016\/j.radonc.2024.110260","article-title":"Assessment of minimum target dose as a predictor of local failure after spine SBRT","volume":"195","author":"Kowalchuk","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2026.102141_bib0033","doi-asserted-by":"crossref","first-page":"101047","DOI":"10.1016\/j.adro.2022.101047","article-title":"Single and multifraction spine stereotactic body radiation therapy and the risk of radiation induced myelopathy","volume":"7","author":"Lucido","year":"2022","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.adro.2026.102141_bib0034","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3171\/SPI-07\/08\/151","article-title":"Phase I\/II study of stereotactic body radiotherapy for spinal metastasis and its pattern of failure","volume":"7","author":"Chang","year":"2007","journal-title":"J Neurosurg Spine"},{"key":"10.1016\/j.adro.2026.102141_bib0035","doi-asserted-by":"crossref","first-page":"5203","DOI":"10.1088\/0031-9155\/56\/16\/008","article-title":"A Monte Carlo pencil beam scanning model for proton treatment plan simulation using GATE\/GEANT4","volume":"56","author":"Grevillot","year":"2011","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.adro.2026.102141_bib0036","doi-asserted-by":"crossref","first-page":"R99","DOI":"10.1088\/0031-9155\/57\/11\/R99","article-title":"Range uncertainties in proton therapy and the role of Monte Carlo simulations","volume":"57","author":"Paganetti","year":"2012","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.adro.2026.102141_bib0037","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.ijrobp.2014.07.037","article-title":"Incidence and predictive factors of pain flare after spine stereotactic body radiation therapy: Secondary analysis of phase 1\/2 trials","volume":"90","author":"Pan","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.adro.2026.102141_bib0038","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jbo.2014.10.001","article-title":"Incidence of pain flare in radiation treatment of bone metastases: A literature review","volume":"3","author":"McDonald","year":"2014","journal-title":"J Bone Oncol"},{"key":"10.1016\/j.adro.2026.102141_bib0039","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/S1470-2045(15)00199-0","article-title":"Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: A double-blind, randomised placebo-controlled, phase 3 trial","volume":"16","author":"Chow","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.adro.2026.102141_bib0040","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1002\/cncr.29882","article-title":"A systematic review of the cost and cost-effectiveness studies of proton radiotherapy","volume":"122","author":"Verma","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.adro.2026.102141_bib0041","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.adro.2018.09.004","article-title":"A comparison of grade 4 lymphopenia with proton versus photon radiation therapy for esophageal cancer","volume":"4","author":"Routman","year":"2019","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.adro.2026.102141_bib0042","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1016\/j.prro.2019.07.010","article-title":"Prediction of severe lymphopenia during chemoradiation therapy for esophageal cancer: Development and validation of a pretreatment nomogram","volume":"10","author":"van Rossum","year":"2020","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.adro.2026.102141_bib0043","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.radonc.2020.12.019","article-title":"Proton beam therapy reduces the risk of severe radiation-induced lymphopenia during chemoradiotherapy for locally advanced non-small cell lung cancer: A comparative analysis of proton versus photon therapy","volume":"156","author":"Kim","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.adro.2026.102141_bib0044","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.adro.2019.02.002","article-title":"Single-fraction stereotactic body radiation therapy versus conventionally fractionated radiation therapy for the treatment of prostate cancer bone metastases","volume":"4","author":"Gao","year":"2019","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.adro.2026.102141_bib0045","article-title":"Comparison of proton versus photon SBRT for treatment of spinal metastases using variable RBE models","volume":"16","author":"Shaaban","year":"2025","journal-title":"Int J Part Ther"},{"issue":"1_suppl","key":"10.1016\/j.adro.2026.102141_bib0046","first-page":"104S","article-title":"Advanced radiotherapy technologies in spine tumors: What the surgeon needs to know","volume":"15","author":"Chen","year":"2025","journal-title":"Glob Spine J"},{"key":"10.1016\/j.adro.2026.102141_bib0047","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2025.111304","article-title":"ESTRO-ISRS clinical practice recommendations for re-irradiation of spinal metastases with stereotactic body radiotherapy: Delphi consensus supported by a systematic review and meta-analysis","volume":"214","author":"Alongi","year":"2026","journal-title":"Radiother Oncol"}],"container-title":["Advances in Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S245210942600148X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S245210942600148X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T11:36:38Z","timestamp":1792064198000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S245210942600148X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":47,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S245210942600148X"],"URL":"https:\/\/doi.org\/10.1016\/j.adro.2026.102141","relation":{},"ISSN":["2452-1094"],"issn-type":[{"value":"2452-1094","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early Clinical Outcomes and Local Control Following Spine Stereotactic Proton Ablative Radiation Therapy","name":"articletitle","label":"Article Title"},{"value":"Advances in Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.adro.2026.102141","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}],"article-number":"102141"}}